Andrew Gerrard
GP/MD at C2 Capital
" Growth, scale-up => series-A+IPO
Tech (agnostic): AI/ML/robotics, FOW, life sciences, deeptech, web3, climate & impact
Intl. investors US & N.America, UK, Europe, MENA & APAC
Market validation +POC, MVP, PMF & FounderMF
Traction MRR/ARR "
Countries of investment
Nigeria
South Africa
Canada
USA
Hong Kong
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Austria
Belgium
Croatia
Cyprus
Czech Republic
Denmark
Estonia
Finland
France
Georgia
Germany
Greece
Iceland
Ireland
Italy
Latvia
Liechtenstein
Lithuania
Luxembourg
Malta
Monaco
Netherlands
Norway
Poland
Portugal
Romania
Serbia
Slovakia
Slovenia
Spain
Sweden
Switzerland
UK
Ukraine
Bahrain
Israel
Kuwait
Qatar
Saudi Arabia
Turkey
UAE
Australia
New Zealand